Status:
UNKNOWN
A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
Prostate brachytherapy is an effective treatment option for men with localized prostate cancer, with excellent cure rates and a favorable toxicity profile. With the current needle insertion technique,...
Eligibility Criteria
Inclusion
- Prostate cancer
- Treated with prostate brachytherapy at the Cross Cancer Institute
- Low and intermediate risk prostate cancer
- ambulatory patients
- stable medical condition
- Over 18 years of age
- Capable of giving informed consent
Exclusion
- Any hormonal therapy
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2017
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01437085
Start Date
October 1 2011
End Date
August 1 2017
Last Update
January 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2